Assessing the predictability of the H3K27M status in diffuse glioma patients using frequency importance analysis on chemical exchange saturation transfer MRI
Magnetic Resonance Imaging · 2023-11 · 103 · 54-60
DOI: 10.1016/j.mri.2023.07.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance Imaging, 2023-11. Verfasst von Yibing Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Information Sciences and Technology, Northwest University, Xi'an 710069, China; Xi'an Key Laboratory of Radiomics and Intelligent Perceptio…. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVES: In diffuse glioma patients, Lys-27-Met mutations in histone 3 genes (H3K27M) are associated with an aggravated prognosis and further decreased overall survival. By using frequency importance analysis on chemical exchange saturation transfer (CEST) MRI, this study aimed to assess the predictability of the H3K27M status in diffuse glioma patients. METHODS: Twenty-two patients diagnosed with diffuse glioma, with a known H3K27M status, were included in the present study. All patients underwent CEST MRI scans. The previously proposed frequency importance analysis was performed to determine the relative contribution of the amide and aliphatic protons for the differentiation between normal tissues and tumors. For this comparison, the conventional MTRasym analysis of amide protons at 3.5 ppm, i.e., the amide proton transfer-weighted (APTw) signal, was employed. Statistical analysis was performed using the Mann-Whitney U test, and the receiver operating characteristic (ROC) and area under the curve (AUC) analyses. RESULTS: The mean and 90th percentile of the ΔAPTw intensities, amide and aliphatic frequency importance values revealed statistically significant differences between the wildtype and the H3K27M-altered patient groups (p < 0.05). For the prediction of the H3K27M status, amide frequency importance achieved highest AUCs of 0.97, with a specificity of 0.93. In contrast, the ΔAPTw intensities and aliphatic frequency importance showed relatively lower AUCs (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Information Sciences and Technology, Northwest University, Xi'an 710069, China; Xi'an Key Laboratory of Radiomics and Intelligent Perception, Northwest University, Xi'an 710069, China.
- Department of Radiology, Beijing Tsinghua Changgung Hospital, Beijing 102218, China.
- Department of Radiology, Beijing Tsinghua Changgung Hospital, Beijing 102218, China. Electronic address: zzza00509@btch.edu.cn.
- Center for Biomedical Imaging Research, Department of Biomedical Engineering, Tsinghua University, Beijing 100084, China. Electronic address: songxl@tsinghua.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, Y., Zhao, B., Zhu, C., Bie, C., He, X., Zheng, Z., & Song, X. (2023). Assessing the predictability of the H3K27M status in diffuse glioma patients using frequency importance analysis on chemical exchange saturation transfer MRI. Magnetic Resonance Imaging, 103, 54-60. https://doi.org/10.1016/j.mri.2023.07.003
Vancouver
Chen Y, Zhao B, Zhu C, Bie C, He X, Zheng Z, et al. Assessing the predictability of the H3K27M status in diffuse glioma patients using frequency importance analysis on chemical exchange saturation transfer MRI. Magnetic Resonance Imaging. 2023;103:54-60. doi:10.1016/j.mri.2023.07.003
BibTeX
@article{Chen2023,
author = {Chen, Yibing and Zhao, Benqi and Zhu, Changhao and Bie, Chongxue and He, Xiaowei and Zheng, Zhuozhao and Song, Xiaolei},
title = {Assessing the predictability of the H3K27M status in diffuse glioma patients using frequency importance analysis on chemical exchange saturation transfer MRI},
journal = {Magnetic Resonance Imaging},
year = {2023},
volume = {103},
pages = {54--60},
doi = {10.1016/j.mri.2023.07.003}
}
EUVIMED